Xantho Biotechnology Co., Ltd.
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Xantho Biotechnology Co., Ltd. is a biotechnology company that develops botanical new drugs for the treatment of dermatological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xantho Biotechnology Co., Ltd. Comparables
Compare Xantho Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alphyn Biologics, Inc. | 80% | |
| Legacy Healthcare SA | 71% | |
| Energenesis Biomedical Co. Ltd. | 71% | |
Xantho Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 233% MoM.
Xantho Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xantho Biotechnology Co., Ltd.'s valuation, stock price, and market status.